+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Transdermal Drug Delivery Market 2024-2028 - Product Thumbnail Image

Transdermal Drug Delivery Market 2024-2028

  • Report
  • November 2023
  • 168 Pages
  • Global
From
From
From
From
Cardiovascular Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 300 Pages
  • Global
From
Alzheimer's Disease Treatment Global Market Report 2024 - Product Thumbnail Image

Alzheimer's Disease Treatment Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Biologics Market Report 2025-2035 - Product Thumbnail Image

Biologics Market Report 2025-2035

  • Report
  • March 2025
  • 367 Pages
  • Global
From
From
From
From
Global Transdermal Drug Delivery Market 2021-2026 - Product Thumbnail Image

Global Transdermal Drug Delivery Market 2021-2026

  • Report
  • June 2021
  • 109 Pages
  • Global
From
Loading Indicator